BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16360132)

  • 1. A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy.
    Watkins SJ; Jonker L; Arthur HM
    Cardiovasc Res; 2006 Feb; 69(2):432-9. PubMed ID: 16360132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
    Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
    Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity.
    van Caam A; Madej W; Garcia de Vinuesa A; Goumans MJ; Ten Dijke P; Blaney Davidson E; van der Kraan P
    Arthritis Res Ther; 2017 May; 19(1):112. PubMed ID: 28569204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent.
    Watkins SJ; Borthwick GM; Oakenfull R; Robson A; Arthur HM
    Hypertens Res; 2012 Apr; 35(4):393-8. PubMed ID: 22072105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway.
    Hocevar BA; Prunier C; Howe PH
    J Biol Chem; 2005 Jul; 280(27):25920-7. PubMed ID: 15894542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.
    Augeri DJ; Langenfeld E; Castle M; Gilleran JA; Langenfeld J
    Mol Cancer; 2016 Apr; 15():27. PubMed ID: 27048361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gramine protects against pressure overload-induced pathological cardiac hypertrophy through Runx1-TGFBR1 signaling.
    Xu L; Su Y; Yang X; Bai X; Wang Y; Zhuo C; Meng Z
    Phytomedicine; 2023 Jun; 114():154779. PubMed ID: 37023527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arjunolic acid, a peroxisome proliferator-activated receptor α agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-β signaling.
    Bansal T; Chatterjee E; Singh J; Ray A; Kundu B; Thankamani V; Sengupta S; Sarkar S
    J Biol Chem; 2017 Oct; 292(40):16440-16462. PubMed ID: 28821620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway.
    Akool el-S; Doller A; Müller R; Gutwein P; Xin C; Huwiler A; Pfeilschifter J; Eberhardt W
    J Biol Chem; 2005 Nov; 280(47):39403-16. PubMed ID: 16183640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
    Yan X; Zhao R; Feng X; Mu J; Li Y; Chen Y; Li C; Yao Q; Cai L; Jin L; Han C; Zhang D
    Cardiovasc Res; 2020 Jan; 116(1):114-126. PubMed ID: 30854566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH.
    Nasim MT; Ogo T; Chowdhury HM; Zhao L; Chen CN; Rhodes C; Trembath RC
    Hum Mol Genet; 2012 Jun; 21(11):2548-58. PubMed ID: 22388934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β-activated kinase 1 (Tak1) mediates agonist-induced Smad activation and linker region phosphorylation in embryonic craniofacial neural crest-derived cells.
    Yumoto K; Thomas PS; Lane J; Matsuzaki K; Inagaki M; Ninomiya-Tsuji J; Scott GJ; Ray MK; Ishii M; Maxson R; Mishina Y; Kaartinen V
    J Biol Chem; 2013 May; 288(19):13467-80. PubMed ID: 23546880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.
    Ungefroren H; Groth S; Ruhnke M; Kalthoff H; Fändrich F
    J Biol Chem; 2005 Jan; 280(4):2644-52. PubMed ID: 15546867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microRNA-15 family inhibits the TGFβ-pathway in the heart.
    Tijsen AJ; van der Made I; van den Hoogenhof MM; Wijnen WJ; van Deel ED; de Groot NE; Alekseev S; Fluiter K; Schroen B; Goumans MJ; van der Velden J; Duncker DJ; Pinto YM; Creemers EE
    Cardiovasc Res; 2014 Oct; 104(1):61-71. PubMed ID: 25103110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats.
    Matsumoto-Ida M; Takimoto Y; Aoyama T; Akao M; Takeda T; Kita T
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H709-15. PubMed ID: 16183734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase.
    Yi JY; Shin I; Arteaga CL
    J Biol Chem; 2005 Mar; 280(11):10870-6. PubMed ID: 15657037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.
    Lebrin F; Goumans MJ; Jonker L; Carvalho RL; Valdimarsdottir G; Thorikay M; Mummery C; Arthur HM; ten Dijke P
    EMBO J; 2004 Oct; 23(20):4018-28. PubMed ID: 15385967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
    Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M
    Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.